Cleopatra Hospital is trading at $13.02, down -6.26%, amid broader pressure in Egyptian equities; no clear company-specific announcement explains the decline.
- The previously reported capital increase was approved on October 20, with a reference-price adjustment scheduled for October 27. Available coverage does not link it to this move.
- The EGX 30 fell 3.56% on October 25, supporting a market-wide sentiment explanation rather than a confirmed company catalyst.